Meng E - Search Results

1

Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer.

Chen F, Pei L, Liu S, Lin Y, Han X, Meng E, Wang X, Hong S, Wang D, Liu F, Fei Y, Wang G. Chen F, et al. Among authors: meng e. Front Genet. 2021 Jun 28;12:684349. doi: 10.3389/fgene.2021.684349. eCollection 2021. Front Genet. 2021. PMID: 34262597 Free PMC article.

2

Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma.

Gao W, Li L, Han X, Liu S, Li C, Yu G, Zhang L, Zhang D, Liu C, Meng E, Hong S, Wang D, Guo P, Shi G. Gao W, et al. Among authors: meng e. BMC Cancer. 2021 Mar 31;21(1):331. doi: 10.1186/s12885-021-08052-8. BMC Cancer. 2021. PMID: 33789609 Free PMC article.

3

Identification of a novel heterozygous germline RAD52 missense mutation in a patient with gallbladder carcinoma: A case report.

Zhao W, Dai Y, Yue L, Gu J, Meng E, Wang D, Liu S, Han X, Wang X, Li G, Dai X. Zhao W, et al. Among authors: meng e. Medicine (Baltimore). 2021 May 14;100(19):e25957. doi: 10.1097/MD.0000000000025957. Medicine (Baltimore). 2021. PMID: 34106670 Free PMC article.

4

Case Report: Triple Primary Malignant Tumors of the Esophagus, Stomach, and Colon in a Patient With Genetic Analysis.

Zhan X, He L, Song K, Cao S, Meng E, Wang Y. Zhan X, et al. Among authors: meng e. Front Genet. 2021 Jul 9;12:676497. doi: 10.3389/fgene.2021.676497. eCollection 2021. Front Genet. 2021. PMID: 34306021 Free PMC article.

5

Dramatic response to local radiotherapy in a refractory metastatic mediastinal yolk sac tumor patient harboring a germline BRCA2 frameshift mutation: a case report.

Cheng X, Yu H, Li J, Han X, Meng E, Zhou H, Wang D, Niu B, Zhang X. Cheng X, et al. Among authors: meng e. Cancer Biol Ther. 2022 Dec 31;23(1):393-400. doi: 10.1080/15384047.2022.2072635. Cancer Biol Ther. 2022. PMID: 35576916 Free PMC article.

6

Long-term response to sintilimab, bevacizumab and chemotherapy in heavily pretreated microsatellite stable colon cancer.

Cui Z, Wang Q, Deng M, Meng E, Liu S, Niu B, Han Q. Cui Z, et al. Among authors: meng e. Immunotherapy. 2023 Feb;15(3):127-133. doi: 10.2217/imt-2022-0058. Epub 2023 Feb 1. Immunotherapy. 2023. PMID: 36722149

7

Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.

Zhang H, Jiang D, Meng E, Zhao M, Niu B. Zhang H, et al. Among authors: meng e. Immunotherapy. 2023 Jan;15(1):17-25. doi: 10.2217/imt-2021-0259. Epub 2023 Jan 17. Immunotherapy. 2023. PMID: 36647794

8

Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma.

Ma J, Wang B, Meng E, Meng X. Ma J, et al. Among authors: meng e, meng x. Gland Surg. 2021 Sep;10(9):2874-2879. doi: 10.21037/gs-21-469. Gland Surg. 2021. PMID: 34733735 Free PMC article.

9

Homozygous deletion of the HLA-B gene as an acquired-resistance mechanism to nivolumab in a patient with lung adenocarcinoma: a case report.

Zhang H, Dong W, Zhao H, Zeng Z, Zhang F, Hu Y, Li Q, Chen J, Meng E, Xiao W. Zhang H, et al. Among authors: meng e. Ann Transl Med. 2021 Oct;9(19):1506. doi: 10.21037/atm-21-3825. Ann Transl Med. 2021. PMID: 34805368 Free PMC article.

10

Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion.

Xie X, You M, Meng E, Wang S, Niu B, Huang W. Xie X, et al. Among authors: meng e. J Cancer Res Clin Oncol. 2022 Sep;148(9):2561-2566. doi: 10.1007/s00432-022-04076-0. Epub 2022 Jun 1. J Cancer Res Clin Oncol. 2022. PMID: 35648195 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters